Category: Research

Jorge Cortes, M.D. will join the Division of Hematology and Oncology as Chief of Hematology; furthermore, Cortes will serve as the Deputy Director of the O'Neal Cancer Center. Similarly, Mehmet Akce, M.D., will serve as Interim Chief of Oncology.

The University of Alabama System Board of Trustees has appointed Anindya Dutta, MBBS, Ph.D., as the next holder of the O’Neal-Sokol Breast Cancer Research Foundation of Alabama (BCRFA) Endowed Chair.

Nature Cancer magazine published a study led by Dr. Stringer-Reasor that highlights a promising advance in the treatment of one of the most challenging complications of breast cancer, leptomeningeal metastasis.

The UAB O’Neal Cancer Center is pleased to announce the latest O’Neal Invests grant awards as part of the 2025 fall cycle.

The UAB O’Neal Cancer Center is pleased to announce that the Breast Cancer Research Foundation of Alabama (BCRFA) has generously funded two grants through the 2025 fall cycle of O’Neal Invests.

The UAB O’Neal Comprehensive Cancer Center hosted its 2024 Iron Strong Awards July 12, honoring nine cancer clinical trial survivors.

The UAB O’Neal Comprehensive Cancer Center is pleased to announce that the Breast Cancer Research Foundation of Alabama (BCRFA) has generously funded […]

The UAB O’Neal Comprehensive Cancer Center is pleased to announce the latest O’Neal […]

The UAB O’Neal Comprehensive Cancer Center is pleased to announce its latest O’Neal Invests grant awards for its fall 2024 cycle.

UAB Medicine and the UAB O’Neal Comprehensive Cancer Center invite all medical professionals involved in caring for patients with lung cancer to attend this annual CME-accredited event on November 1-2, 2024.

The UAB O’Neal Comprehensive Cancer Center hosted its 2024 Iron Strong Awards July 12, honoring nine cancer clinical trial survivors.

The UAB O’Neal Comprehensive Cancer Center is pleased to announce that the BCRFA has generously funded two catalyst grants through the spring cycle of O’Neal Invests.

The UAB O’Neal Comprehensive Cancer Center is pleased to announce its spring 2024 O’Neal Invests grant awards.

New technology presents new opportunities in patient care, something that Yogesh Kumar, Ph.D., knew well when he began researching the use of machine-learning software in cancer treatment. When he received this year’s Mary Ann Harvard NextGen Scholar Award for his work integrating artificial intelligence into radiotherapy, he knew he was on the right track.

Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months with concomitant temozolomide chemotherapy.

Over the past decade, the University of Alabama at Birmingham has become a national leader in clinical trials — studies examining the use of new treatments in people. And more patients than ever in Alabama have access to life-changing therapies at UAB.

A nationwide study of 196 cities shows that housing discrimination from 90 years ago still casts a historical shadow of inequities in colon cancer care today, S.M. Qasim Hussaini, M.D., of the University of Alabama at Birmingham and colleagues at the American Cancer Society and Johns Hopkins School of Public Health report in the journal JCO Oncology Practice.

Mark your calendars for this year's State of the Science Summit: Hematologic Malignancies coming to Birmingham on May 23, 2024.

The University of Alabama at Birmingham’s Isabel Scarinci, Ph.D., vice chair for Global and Rural Health in the Department of Obstetrics and Gynecology, was chosen to lead a workgroup charged with creating the United States cervical cancer elimination plan.  

When members of the O’Neal Comprehensive Cancer Center investigate complex questions together, the new therapies, discoveries and patient care improvements that result become more than the sum of the parts

The O’Neal Comprehensive Cancer Center at UAB is pleased to announce that the Breast Cancer Research Foundation of Alabama (BCRFA) has generously funded three Pre-R01 grants through the fall cycle of O’Neal Invests.

The advisory board of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham will host its 39th annual ArtBLINK Gala on Saturday, Feb. 3, at 6:30 p.m. in the UAB Kirklin Clinic.

The O’Neal Comprehensive Cancer Center at UAB is pleased to announce its fall 2023 O’Neal Invests grant awards.

UAB’s Breast Cancer Team presented at the San Antonio Breast Cancer Symposium (SABCS) December 5 through December 9, 2023.